VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CHCTCommunity Healthcare Trust Incorporated
$18.33$524M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCHCTCash Flow

Community Healthcare Trust Incorporated (CHCT) Cash Flow Statement

12Y historyFree accessUpdated daily

Dividend sustainability appears highly questionable as the payout ratio relative to AFFO frequently exceeds 100%, such as the 1.07x ratio observed in 2025Q3.

CHCT Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Cash from Operations55.76M56.43M58.88M61.38M60.28M56.35M48.37M32.36M24.44M22.13M14.93M2.97M0
Operating CF Growth %-31.32%-4.16%-4.08%1.83%6.98%16.49%49.47%32.41%10.46%48.21%402.49%--
Operating CF / Revenue %45.57%46.56%50.85%54.4%61.71%62.21%63.91%53.18%50.26%59.25%59.25%34.42%0%
Net Income6.06M5.1M-3.18M7.71M22.02M22.49M19.08M8.38M4.4M3.51M2.72M-1.46M7.58M
Depreciation & Amortization42.91M43.54M42.78M40.44M33.19M31.23M25.51M22.75M20.17M18.15M13.38M5.32M0
Stock-Based Compensation10.31M10.3M9.99M19.96M9.41M7.16M4.74M3.84M2.85M1.47M674K166K0
Other Non-Cash Items-3.46M-2.15M10.11M-3.66M-3.44M-3.81M-2.9M-2.05M3.55M-1.24M-1.89M-133K-7.58M
Working Capital Changes-75K-388K-809K-3.38M-943K-894K1.86M-1.98M-4.99M709K-119K-997K0
Cash from Investing-62.57M-47.7M-92.66M-113.67M-113.77M-104.43M-125.06M-153.18M-53.51M-147.55M-117.09M-140.64M0
Acquisitions (Net)0000103.4M97.21M118.07M000000
Purchase of Investments0000-106.4M-102.45M-128.57M0-52.22M-147.25M-115.61M-139.81M0
Sale of Investments00003M5.24M10.5M03.27M833K104K00
Other Investing-62.57M-47.7M-92.66M-113.67M-103.4M-97.21M-118.07M-148.81M-48.95M-146.42M-115.51M-139.81M0
Cash from Financing7.16M-9.78M33.53M44.86M62.69M48.05M77.56M120.45M29.33M125.99M101.71M139.69M0
Dividends Paid-54.08M-53.67M-51.7M-48.06M-44.48M-42.41M-38.03M-31.95M-29.38M-24.43M-17.78M-3.93M0
Common Dividends-40.41M-53.67M-51.7M-48.06M-44.48M-42.41M-38.03M-31.95M-29.38M-24.43M-17.78M-3.93M0
Debt Issuance (Net)1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K0
Share Repurchases419K-1.79M00000000000
Other Financing70.81M-317K-4.44M-1.19M-1.24M-1.86M-269K-1.75M9.7M-1.75M-1.31M-2.74M0
Net Change in Cash346K-1.04M-249K-7.43M9.2M-25K869K-369K262K562K-450K2.02M0
Exchange Rate Effect0000000000000
Cash at Beginning3.34M4.38M4.63M12.07M2.87M2.89M2.02M2.39M2.13M1.57M2.02M2K0
Cash at End2.62M3.34M4.38M4.63M12.07M2.87M2.89M2.02M2.39M2.13M1.57M2.02M0
Free Cash Flow60.44M56.43M34.24M42.4M49.9M49.13M41.38M27.99M19.88M21M13.35M2.14M0
FCF Growth %65.9%64.82%-19.26%-15.03%1.58%18.74%47.82%40.77%-5.29%57.27%522.67%--
FCF / Revenue %49.39%46.56%29.57%37.58%51.09%54.24%54.67%46%40.89%56.22%52.98%24.84%0%

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Dividend coverage and payout sustainability

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Dividend Coverage Remains Highly Precarious

As reported in financial statements, CHCT's dividend payout ratio relative to AFFO frequently exceeds 100%, with a notable 1.07x ratio in 2025Q3, suggesting that the company is consistently distributing more cash than its core operations generate after accounting for necessary recurring capital expenditures.

The recurring inability to cover the dividend with AFFO suggests that the current distribution level may be unsustainable without external capital support. Investors should monitor whether management intends to adjust the payout or if they are relying on asset sales to bridge the persistent shortfall in distributable cash.

FFO Quality Masked by Volatility

Based on the provided data, the conversion of GAAP operating cash flow to FFO is highly inconsistent, with FFO/NI ratios swinging from -1.60 in 2024Q2 to 9.06 in 2025Q1, indicating that non-cash items and accounting adjustments significantly distort the company's reported earnings performance.

This extreme variance implies that FFO is not a reliable proxy for cash generation in any single quarter. The disconnect between operating cash flow and FFO suggests that investors should prioritize cash-based metrics over accounting-driven earnings to assess the true health of the business.

Capital Expenditures Impairing Cash Flow

According to recent SEC filings, CHCT's recurring capital expenditures, including tenant improvements and leasing commissions, frequently consume a substantial portion of operating cash flow, as evidenced by the $7.2 million in capex recorded during both 2024Q2 and 2024Q3, which directly reduces available distributable cash.

The high level of maintenance capex relative to FFO suggests that the portfolio requires significant ongoing reinvestment to maintain occupancy. This capital intensity limits the company's ability to retain cash for deleveraging or internal growth, forcing a reliance on external financing to fund the dividend.

Depreciation Obscures Operational Reality

As indicated by the provided financial data, the persistent gap between GAAP Net Income and FFO, highlighted by the $12.6 million net loss in 2025Q2, demonstrates that heavy non-cash depreciation charges are masking the underlying cash-generating capacity of the healthcare facility portfolio.

While depreciation is a non-cash expense, the magnitude of these charges relative to net income suggests that the company's GAAP bottom line is a poor indicator of operational success. Analysts must continue to strip away these accounting distortions to evaluate whether the underlying assets are truly performing as expected.

CHCT — Frequently Asked Questions

Quick answers to the most common questions about buying CHCT stock.

How much cash does Community Healthcare Trust Incorporated (CHCT) generate from operations?

Community Healthcare Trust Incorporated (CHCT) generated $56.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Community Healthcare Trust Incorporated's free cash flow?

Community Healthcare Trust Incorporated (CHCT) generated $56.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Community Healthcare Trust Incorporated's capital expenditure (CapEx)?

Community Healthcare Trust Incorporated (CHCT) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Community Healthcare Trust Incorporated distribute cash to shareholders?

In 2025, Community Healthcare Trust Incorporated (CHCT) returned $53.7M to shareholders via cash dividends and spent $1.8M on share repurchases. This shows the company's commitment to returning capital to its equity investors.